Healthcare Dealmakers Converge on San Francisco as 2026 Shapes Up for Landmark Mergers
Global healthcare executives and investors head to San Francisco with renewed optimism, as easing regulatory pressures and strong balance sheets
Read More
Factual Version of a Story
biotech valuation trends